Kario Kazuomi, Nishiyama Akira, Shibata Shigeru, Mogi Masaki, Arima Hisatomi, Kishi Takuya, Ishida Mari, Furuhashi Masato, Ichihara Atsuhiro, Katsuya Tomohiro, Miura Katsuyuki, Miura Shin-Ichiro, Ohishi Mitsuru, Shibata Hirotaka, Shimosawa Tatsuo, Sugawara Akira, Tamura Kouichi, Toyoda Kazunori, Yamamoto Koichi, Hoshide Satoshi, Nakagawa Naoki, Tomita Hirofumi, Tanaka Atsushi, Hozawa Atsushi, Hatta Tsuguru, Nomura Akihiro, Kabayama Mai, Rakugi Hiromi, Ohya Yusuke, Node Koichi
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Hypertens Res. 2025 Aug 26. doi: 10.1038/s41440-025-02330-9.
Hypertension is the greatest risk factor for cardiovascular diseases and significantly contributes to cardiovascular mortality. In Japan, the hypertensive population is estimated at 43 million, with only 27% achieving well-controlled blood pressure (BP). The onset of major cardiovascular events, including stroke, myocardial infarction, heart failure, and aortic dissection, frequently occurs during the early morning hours. Accordingly, for over 20 years, the Japanese Society of Hypertension (JSH) has prioritized the management of early morning hypertension and has emphasized the importance of antihypertensive treatment guided by home BP in its treatment guidelines. However, even among hypertensive patients with multiple medications, control of morning BP remains suboptimal, with fewer than 30% achieving target levels below 130/80 mmHg. To address this serious situation, JSH announced their Declaration for the Eradication of Morning Hypertension in 2025, in conjunction with the release of the Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025. The primary specific measure of the declaration involves the Asakatsu BP Action Plan - the Morning Blood Pressure 130 Campaign - which encourages individuals to monitor their morning blood pressure (BP) in various settings, such as homes, workplaces, and BP kiosks set up in public spaces. Additionally, JSH is promoting a Systematic Review Project to raise awareness of the importance of early morning hypertension management nationally and internationally, and a Data Science Project to examine how digital technology can contribute to the promotion of personalized and anticipation medicine through "digital hypertension" research.
高血压是心血管疾病的最大危险因素，对心血管疾病死亡率有显著影响。在日本，高血压患者估计有4300万，只有27%的患者血压得到良好控制。包括中风、心肌梗死、心力衰竭和主动脉夹层在内的重大心血管事件，经常在清晨时段发生。因此，20多年来，日本高血压学会（JSH）一直将清晨高血压的管理作为优先事项，并在其治疗指南中强调了家庭血压指导下的降压治疗的重要性。然而，即使在使用多种药物治疗的高血压患者中，清晨血压的控制仍不理想，只有不到30%的患者血压达到130/80 mmHg以下的目标水平。为应对这一严峻形势，JSH在发布《2025年血压升高和高血压管理指南》的同时，宣布了“2025年根除清晨高血压宣言”。该宣言的主要具体措施包括“朝醒血压行动计划——清晨血压130运动”，鼓励人们在家庭、工作场所和公共场所设立的血压测量站等各种环境中监测自己的清晨血压。此外，JSH正在推动一项系统评价项目，以提高国内和国际上对清晨高血压管理重要性的认识，以及一项数据科学项目，通过“数字高血压”研究来研究数字技术如何有助于促进个性化和预测性医学。
